Giuseppe Curigliano

Clin Cancer Res 2020 Jan 16;26(2):354-363. Epub 2019 Oct 16.

European Institute of Oncology, IRCCS, and University of Milan, Milan, Italy.

Clin Cancer Res 2020 Jan 14. Epub 2020 Jan 14.

"Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Azienda USL Toscana Centro

Cancer Treat Rev 2020 Jan 13;84:101963. Epub 2020 Jan 13.

Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy. Electronic address:

Eur J Cancer 2020 Jan 20. Epub 2020 Jan 20.

European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy. Electronic address:

Public Health Genomics 2020 Jan 28:1-4. Epub 2020 Jan 28.

Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Cancer Treat Rev 2019 12 6;81:101913. Epub 2019 Nov 6.

Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

N Engl J Med 2019 Dec 11. Epub 2019 Dec 11.

From M.D. Anderson Cancer Center, Houston (R.K.M., G.H.); Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (S. Loi); the Royal Marsden NHS Foundation Trust, London (A.O.), and Edinburgh Cancer Research Centre, Edinburgh (D.C.) - both in the United Kingdom; Winship Cancer Institute, Atlanta (E.P.); Sarah Cannon Research Institute/Tennessee Oncology-Nashville (E.H.) and Vanderbilt University Medical Center (V.A.), Nashville; University of California, Los Angeles, Medical Center-Jonsson Comprehensive Cancer Center, Los Angeles (S.A.H., D.S.), and Stanford Comprehensive Cancer Institute, Palo Alto (M.P.) - both in California; Dana-Farber Cancer Institute, Boston (N.U.L., I.K., E.P.W.); University of Colorado Cancer Center, Aurora (V.B.); Duke Cancer Institute, Durham (C.A.), and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill (L.A.C.) - both in North Carolina; University Health Network, Princess Margaret Cancer Centre, Toronto (P.L.B.), and British Columbia Cancer, Vancouver (K.G.) - both in Canada; Hospital Universitario Vall D'Hebron, Barcelona (M.O.); Sygehus Lillebaelt-Vejle Sygehus, Vejle, Denmark (E.J.); Centre Léon Bérard, Lyon, France (T.B.); Rambam Health Care Campus, Haifa, Israel (S.S.S.); Universitaetsklinikum Hamburg-Eppendorf, Hamburg (V.M.), and German Breast Group, Neu-Isenburg (S. Loibl) - both in Germany; Hospital Cuf Descobertas R. Mário Botas, Lisbon, Portugal (S.B.); Cliniques Universitaires Saint-Luc, Brussels (F.P.D.); Third Medical Department, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials, and Cancer Cluster Salzburg, Salzburg, Austria (R.G.); Istituto Europeo di Oncologia, IRCCS, University of Milan, Milan (G.C.); and Seattle Genetics, Bothell, WA (M.C.P.-W., L.W., W.F.).

Lancet Oncol 2019 Dec 16. Epub 2019 Dec 16.

GBG Forschungs GmbH and Centre for Haematology and Oncology, Bethanien, Frankfurt, Germany.

Breast 2019 Dec 12;49:202-209. Epub 2019 Dec 12.

Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Breast Care (Basel) 2019 Dec 16;14(6):359-365. Epub 2019 Oct 16.

Breast Surgical Oncology Unit, Clinica Universidad de Navarra, Madrid, Spain.

Breast Care (Basel) 2019 Dec 24;14(6):373-381. Epub 2019 Sep 24.

Department of Breast Tumours, Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania.

Oncologist 2019 Nov 7;24(11):e1034-e1043. Epub 2019 May 7.

Cardiology Division, European Institute of Oncology, Milan, Italy.

Curr Opin Oncol 2019 Nov;31(6):469-471

IEO, European Institute of Oncology IRCCS.

Curr Opin Oncol 2019 Nov;31(6):472-479

IEO, European Institute of Oncology IRCCS.

Eur J Cancer 2019 Nov 10;122:22-41. Epub 2019 Oct 10.

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Biosciences, University of Milan, Milan, Italy. Electronic address:

JAMA Oncol 2019 Nov 7:1-8. Epub 2019 Nov 7.

Bras and Family Drug Development Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

Adv Exp Med Biol 2019 ;1168:9-30

Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Breast Cancer Res 2019 11 21;21(1):123. Epub 2019 Nov 21.

Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.

Expert Opin Biol Ther 2019 Oct 10;19(10):1015-1021. Epub 2019 Jul 10.

Division of Early Drug Development for Innovative Therapy, European Institute of Oncology IRCCS , Milan , Italy.

Eur J Cancer 2019 Oct 21;120:1-9. Epub 2019 Aug 21.

Samsung Bioepis Co., Ltd., Incheon, Republic of Korea.

Expert Opin Pharmacother 2019 Oct 9;20(15):1809-1818. Epub 2019 Sep 9.

Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS , Milan , Italy.

Drugs 2019 Oct;79(15):1609-1624

Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.

Eur J Cancer 2019 Sep 11;118:41-48. Epub 2019 Jul 11.

Department of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan. Electronic address:

Expert Rev Anticancer Ther 2019 Sep 28;19(9):811-822. Epub 2019 Aug 28.

Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS , Milan , Italy.

Eur J Cancer 2019 Aug 21;117:1-4. Epub 2019 Jun 21.

European Institute of Oncology, IRCCS, Italy; University of Milano, Milano, Italy. Electronic address:

Eur J Cancer 2019 Aug 21;117:14-31. Epub 2019 Jun 21.

New Drugs and Early Drug Development for Innovative Therapies Division, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milano, Department of Hematology and Hemato-Oncology, Italy. Electronic address:

NPJ Breast Cancer 2019 29;5:27. Epub 2019 Aug 29.

1Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Handb Exp Pharmacol 2018;249:161-180

Early Drug Development for Innovative Therapy Division, European Institute of Oncology, Via Ripamonti, 435 20141, Milan, Italy.

Handb Exp Pharmacol 2018;249:289-297

Division of Experimental Cancer Medicine, Istituto Europeo di Oncologia, Milano, Italy.

Breast 2019 Jun 20;45:15-21. Epub 2019 Feb 20.

Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, via Ripamonti 435, 20141, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, via Festa del Perdono 7, 20122, Milan, Italy.

Cells 2019 06 18;8(6). Epub 2019 Jun 18.

Department of Experimental Oncology, European Institute of Oncology IRCCS, 20139 Milan, Italy.

Expert Opin Biol Ther 2019 May 1;19(5):383-385. Epub 2019 Apr 1.

a Division of Early Drug Development for Innovative Therapy , IEO, European Institute of Oncology IRCCS , Milan , Italy.

Reprod Biomed Online 2019 May 10;38(5):835-844. Epub 2019 Jan 10.

Fertility Clinic, Research Laboratory on Human Reproduction, CUB-Erasme and Université Libre de Bruxelles, Brussels, Belgium.

Cancer Cell 2019 May 25;35(5):798-815.e5. Epub 2019 Apr 25.

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, via Adamello 16, 20139 Milan, Italy; Department of Biosciences, University of Milan, 20100 Milan, Italy. Electronic address:

BMC Med 2019 05 9;17(1):90. Epub 2019 May 9.

Division of Early Drug Development for Innovative Therapy, European Institute of Oncology (IEO), IRCCS, Milan, Italy.

Breast Cancer Res 2019 05 29;21(1):71. Epub 2019 May 29.

"Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Prato, Italy.

Breast 2019 Apr 7;44:128-134. Epub 2019 Feb 7.

IEO, European Institute of Oncology IRCCS, Milan Italy; University of Milan, Italy. Electronic address:

Cancer Treat Rev 2019 Mar 19;74:21-28. Epub 2019 Jan 19.

Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Lancet Oncol 2019 Mar 11;20(3):371-382. Epub 2019 Feb 11.

Institut Gustave Roussy, Université Paris Sud, INSERM U981, Villejuif, France.

JAMA Oncol 2019 Mar 28. Epub 2019 Mar 28.

Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology, IRCCS Milano, Milan, Italy.

Breast 2019 Feb 6;43:130-134. Epub 2018 Dec 6.

IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hematology, University of Milano, Milan, Italy. Electronic address:

Drug Saf 2019 02;42(2):157-158

Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Drug Saf 2019 02;42(2):247-262

Pharmaceutical Consultant, 8 Birchdale, Gerrards Cross, Buckinghamshire, SL9 7JA, UK.

Expert Rev Clin Pharmacol 2019 Jan 4;12(1):9-16. Epub 2018 Dec 4.

a Division of Early Drug Development for Innovative Therapies , IEO, European Institute of Oncology, IRCCS Milano , Milano , Italy.

Crit Rev Oncol Hematol 2019 Jan 26;133:171-182. Epub 2018 Nov 26.

Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy. Electronic address:

Breast 2018 Dec 22;42:41-49. Epub 2018 Aug 22.

Fertility and Procreation Unit, Gynecologic Oncology Department, IRCCS European Institute of Oncology, European School of Oncology (ESO), Milan, Italy.

Crit Rev Oncol Hematol 2018 Dec 3;132:125-129. Epub 2018 Oct 3.

Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, via Festa del Perdono 7, 20122 Milan, Italy.

Semin Cancer Biol 2018 10 27;52(Pt 2):253-258. Epub 2018 May 27.

Division of Early Drug Development, Istituto Europeo di Oncologia, University of Milano, Department of Haematology and Oncology, Via Ripamonti 435, 20141, Milano, Italy. Electronic address:

Future Oncol 2018 Oct 1;14(23):2403-2414. Epub 2018 Jun 1.

Pfizer Ltd, Sandwich, Kent, UK.

ESMO Open 2018 21;3(6):e000423. Epub 2018 Sep 21.

Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

ESMO Open 2018 21;3(6):e000422. Epub 2018 Sep 21.

Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Eur J Surg Oncol 2018 08 22;44(8):1142-1147. Epub 2018 May 22.

University of Milano, Department of Oncology and Hemato-Oncology, Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address:

Oncotarget 2018 Aug 3;9(60):31709-31718. Epub 2018 Aug 3.

Highlands Oncology Group, 72703, Fayetteville, AR, USA.

Eur J Cancer 2018 07 17;97:1-6. Epub 2018 May 17.

Division of New Drug Development, European Institute of Oncology, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy. Electronic address:

N Engl J Med 2018 07;379(1):93

University of Milan, Milan, Italy

Eur J Cancer 2018 05 20;94:126-137. Epub 2018 Mar 20.

Cardioncology Division, European Institute of Oncology, Milano, Italy.

NPJ Breast Cancer 2018 22;4:12. Epub 2018 May 22.

2Department of Hematology and Oncology, European Institute of Oncology, University of Milano, Via Ripamonti 435, 20141 Milano, Italy.

Biomed Res Int 2017 10;2017:4719194. Epub 2017 Jul 10.

Division of Early Drug Development, European Institute of Oncology, Via Ripamonti 435, Milan, Italy.

Expert Opin Drug Discov 2018 04 7;13(4):339-346. Epub 2018 Feb 7.

a Division of Early Drug Development , European Institute of Oncology , Milano , Italy.

Lancet Oncol 2018 04 28;19(4):434-436. Epub 2018 Feb 28.

Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology, 20141 Milan, Italy. Electronic address:

Cancer Treat Rev 2018 Apr 22;65:22-32. Epub 2018 Feb 22.

Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy.

Expert Opin Biol Ther 2018 04;18(4):483-493

a University of Milano, Department of Oncology and Hemato-Oncology, Division of Early Drug Development for Innovative Therapies , European Institute of Oncology , Milano , Italia.

Lancet Oncol 2018 03 9;19(3):323-336. Epub 2018 Feb 9.

Department of Medical Oncology, Institut Curie (Hôpital René Huguenin) Saint-Cloud, France.

Expert Opin Pharmacother 2018 Feb 22;19(3):299-305. Epub 2018 Jan 22.

a Division of Early Drug Development , European Institute of Oncology , Milan , Italy.

Nature 2018 02;554(7690):35-36

Eur J Cancer 2018 01 8;89:49-55. Epub 2017 Dec 8.

European Institute of Oncology, Division of New Drug Development, Italy; Department of Oncology and Hematology, University of Milano, Milano, Italy. Electronic address:

Breast Cancer (Dove Med Press) 2018 30;10:23-29. Epub 2018 Jan 30.

European Institute of Oncology, Milano, Italy.

Breast 2017 Dec 19;36:86-88. Epub 2017 Jul 19.

Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal.

Biochim Biophys Acta Rev Cancer 2017 Dec 20;1868(2):527-537. Epub 2017 Oct 20.

Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Baselga Institute of Oncology, Madrid, Spain. Electronic address:

Eur J Cancer 2017 12 15;87:164-171. Epub 2017 Nov 15.

Division of Early Drug Development, European Institute of Oncology, Milano, Italy; Department of Haematology and Oncology, University of Milano, Italy. Electronic address:

Adv Anat Pathol 2017 Nov;24(6):311-335

Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ.

Curr Opin Oncol 2017 Nov;29(6):428-433

Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy.

Curr Opin Oncol 2017 Nov;29(6):411-427

New Drugs Development Division, European Institute of Oncology, Milan, Italy.

Eur J Cancer 2017 11 19;86:257-265. Epub 2017 Oct 19.

Department of Medical, Surgery and Health Sciences, University of Trieste, Piazza Ospitale 1, 34129 Trieste, Italy; Breast Cancer Unit and Translational Research Unit, ASST Cremona, Viale Concordia 1, 26100 Cremona, Italy.

Eur J Radiol 2017 Oct 4;95:96-101. Epub 2017 Aug 4.

Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia and Division of Radiology, National Center of Oncological Hadrontherapy (CNAO Foundation), Italy. Electronic address:

Adv Anat Pathol 2017 Sep;24(5):235-251

Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ.

Breast 2017 Aug 23;34:89-95. Epub 2017 May 23.

University Hospital Jean Minjoz, Besançon, France.

J Clin Oncol 2017 Aug 29;35(23):2600-2603. Epub 2017 Jun 29.

Giuseppe Curigliano and Carmen Criscitiello, Istituto Europeo di Oncologia, Milano, Italy.

Expert Opin Investig Drugs 2017 Aug 24;26(8):965-971. Epub 2017 Jul 24.

a Division of Early Drug Development , European Institute of Oncology , Milan , Italy.

Breast Care (Basel) 2017 Jul 27;12(3):136-137. Epub 2017 Jun 27.

Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Milan, Italy.

Breast Care (Basel) 2017 Jul 27;12(3):152-158. Epub 2017 Jun 27.

Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania.

Med Oncol 2017 05 31;34(5):75. Epub 2017 Mar 31.

Azienda Ospedaliero Universitaria Careggi - University of Florence, Largo G.A. Brambilla 3, 50134, Florence, Italy.

Expert Opin Drug Metab Toxicol 2017 May 21;13(5):575-581. Epub 2017 Apr 21.

a Early Drugs Development for Innovative Therapies Division , European Institute of Oncology , Milan , Italy.

Eur J Cancer 2017 04 24;75:245-258. Epub 2017 Feb 24.

Department of Medical, Surgery and Health Sciences, University of Trieste, Piazza Ospitale 1, 34129 Trieste, Italy; Unit of Molecular Therapy and Pharmacogenomic, ASST Cremona, Viale Concordia 1, 26100 Cremona, Italy.

Breast 2017 Feb 2;31:51-56. Epub 2016 Nov 2.

Division of Breast Surgery, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy.

Breast 2017 Feb 17;31:303-308. Epub 2016 Nov 17.

Division of Pathology, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy; University of Milan, Breast Cancer Program, Via Ripamonti 435, 20133 Milano, Italy.

Breast 2017 Feb 19;31:241-243. Epub 2016 Nov 19.

European Institute of Oncology, Milano, Italy; University of Milan, Milano, Italy.

Oncoimmunology 2017 6;6(2):e1253654. Epub 2017 Feb 6.

Tumor Biology, Immunology, and Therapy Section, Division of Translational Medicine, Research Branch, Sidra Medical and Research Center , Doha, Qatar.

Oncotarget 2017 Jan;8(2):2320-2328

Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy.

Curr Oncol Rep 2017 Jan;19(1)

Division of Experimental Cancer Medicine, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141+, Milan, Italy.

Oncotarget 2016 Dec;7(49):80901-80915

Department of Experimental Oncology, European Institute of Oncology, Milan 20141, Italy.

Cancer Treat Rev 2016 Nov 6;50:205-207. Epub 2016 Oct 6.

Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address:

Breast 2016 Oct;29:186-7

Division of Experimental Cancer Medicine, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy. Electronic address:

Ther Adv Med Oncol 2016 Sep 10;8(5):360-74. Epub 2016 Jul 10.

Division of Experimental Therapeutics, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141 Milano, Italy.

Oncotarget 2016 08;7(32):51184-51192

Division of Experimental Therapeutics, Istituto Europeo di Oncologia, Milano, Italy.

Crit Rev Oncol Hematol 2016 Aug 15;104:131-7. Epub 2016 Jun 15.

Pfizer Inc., 235 East 42nd Street, New York, NY 10017-5755, USA. Electronic address:

Anticancer Res 2016 Jul;36(7):3537-40

Division of Experimental Therapeutics, University of Milan-Bicocca, Milan, Italy

Breast Cancer Res Treat 2016 07 2;158(2):323-31. Epub 2016 Jul 2.

Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy.

Ann Transl Med 2016 Jul;4(14):273

Division of Experimental Therapeutics, European Institute of Oncology, Milano, Italy.

J Card Fail 2016 Jun 30;22(6):465-71. Epub 2016 Mar 30.

Philadelphia, Pennsylvania.